Strs Ohio Buys 3,454 Shares of Stryker Corporation $SYK

Strs Ohio lifted its position in Stryker Corporation (NYSE:SYK) by 3.4% during the first quarter, HoldingsChannel.com reports. The fund owned 105,653 shares of the medical technology company’s stock after purchasing an additional 3,454 shares during the period. Strs Ohio’s holdings in Stryker were worth $34,717,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of SYK. Sankala Group LLC bought a new stake in Stryker in the fourth quarter valued at approximately $26,000. Godfrey Financial Associates Inc. bought a new position in shares of Stryker during the fourth quarter worth $26,000. United Financial Planning Group LLC acquired a new position in shares of Stryker in the 3rd quarter valued at $27,000. Atlas Capital Advisors Inc. acquired a new position in shares of Stryker in the 4th quarter valued at $27,000. Finally, DJE Kapital AG bought a new stake in shares of Stryker in the 4th quarter valued at $28,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the company. Sanford C. Bernstein set a $410.00 price objective on Stryker in a research note on Friday, May 1st. Barclays lowered their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Robert W. Baird set a $385.00 price objective on Stryker in a report on Friday, May 1st. Weiss Ratings lowered Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 4th. Finally, Truist Financial reissued a “hold” rating and set a $330.00 target price (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $395.33.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the sale, the director directly owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. The trade was a 13.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the transaction, the vice president owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This represents a 30.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 323,264 shares of company stock valued at $100,659,489. Corporate insiders own 4.60% of the company’s stock.

Stryker Stock Down 0.0%

SYK stock opened at $326.41 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The stock has a market capitalization of $125.13 billion, a P/E ratio of 37.78, a P/E/G ratio of 2.09 and a beta of 0.77. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87. The business has a 50-day moving average of $309.80 and a 200-day moving average of $338.87.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. During the same period in the prior year, the business posted $2.84 EPS. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, sell-side analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.